Theo Buunen
Advisory Board Member
Oncology
Aglaia BioMedical Ventures
Netherlands
Biography
Dr. Buunen obtained his PhD in 1976 at the University of Delft, did a post doc in Madison Wisconsin and obtained an MBA at the University of Twente (Netherlands) in 1982. Dr. Buunen retired in 2012 from his position as CEO of Sanquin in Amsterdam. In his 12 years as CEO, he reorganised the blood banking business of Sanquin from 22 separate centers into a single national blood bank with increased efficiency and quality of products. He is currently on the board of several Dutch organisations in a non-executive capacity.
Research Interest
Oncology